Company Filing History:
1 out of 15 
1 out of 832,966 Years Active: 2000-2002
Title: Innovations of Aleksandra Ewa Tobin
Introduction
Aleksandra Ewa Tobin is a prominent inventor based in Lincoln University, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of integrin receptor antagonists. With a total of 2 patents, her work has the potential to impact various medical conditions.
Latest Patents
Tobin's latest patents focus on novel fused heterocycles that serve as antagonists of integrin receptors. These inventions are crucial for pharmaceutical compositions aimed at inhibiting cell adhesion and treating a range of conditions, including angiogenic disorders, inflammation, cancer metastasis, and diabetic retinopathy. The compounds developed by Tobin can be used alone or in combination with other therapeutic agents, showcasing their versatility in medical applications.
Career Highlights
Throughout her career, Tobin has worked with notable companies, including DuPont Pharmaceuticals, Inc. Her experience in the pharmaceutical industry has equipped her with the knowledge and skills necessary to innovate in her field.
Collaborations
Tobin has collaborated with various professionals, including her coworker John Wityak, to advance her research and development efforts.
Conclusion
Aleksandra Ewa Tobin's contributions to the field of pharmaceuticals through her patents on integrin receptor antagonists highlight her innovative spirit and dedication to improving medical treatments. Her work continues to pave the way for advancements in the treatment of complex health conditions.